A Study of BLB-201 RSV Vaccine in Infants and Children

Clinical trial NCT05655182 · RECRUITING

Trial details

NCT number: NCT05655182
Sponsor: Blue Lake Biotechnology Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2023-03-09
Primary completion: 2028-12-30
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.